All materials

Asymmetric dimethylarginine: ADMA metabolism and vascular risk

ADMA release from methylated proteins, DDAH1 and DDAH2 catalytic evidence, AGXT2, arginine transport, and NOS inhibition. Clinical associations, measurement methods, and why a reference interval is not a treatment threshold.